News

Mauna Kea Technologies Announces its 2025 Financial Calendar

14 January 2025

Paris and Boston, January 14, 2025 – 5:45 p.m. CET – Mauna Kea Technologies (Euronext Growth: ALMKT), inventor of Cellvizio®, the multidisciplinary probe and needle-based confocal laser endomicroscopy (p/nCLE)
platform, today announces the publication of its 2025 Financial Calendar.

EventsDates*
Fourth Quarter 2024 SalesJanuary 15, 2025
Full-Year 2024 Financial ResultsApril 24, 2025
Annual General MeetingJune 5, 2025
Half-Year 2025 Financial ResultsOctober 2, 2025

*Subject to modification. Press releases are published after market closes.

READ THE FULL PRESS RELEASE

Latest News

Mauna Kea Technologies Announces Major Milestone for Cellvizio® in Pancreatic Cysts with CLIMB Study Selected for ASGE Presidential Plenary Session at DDW 2026 

Mauna Kea Technologies Announces Major Milestone for Cellvizio® in Pancreatic Cysts with CLIMB Study Selected for ASGE Presidential Plenary Session at DDW 2026 

Mauna Kea Technologies Accelerates International Expansion with New Regulatory Clearances in Switzerland and the United Kingdom 

Mauna Kea Technologies Accelerates International Expansion with New Regulatory Clearances in Switzerland and the United Kingdom 

Mauna Kea Technologies Announces CE MDR Certification For Cellvizio® and Its Associated Probes

Mauna Kea Technologies Announces CE MDR Certification For Cellvizio® and Its Associated Probes

No results found.